MetaCap

Dogwood Therapeutics Insider Trades

NASDAQ: DWTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.40-0.01 (-0.71%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Dogwood Therapeutics insider activity

Over the last 12 months, Dogwood Therapeutics insiders reported 2 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Sealbond Ltd & Conjoint Inc. & CK Life Sciences Intl (Holdings) Inc (Director) reporting a transaction in 21,610,950 shares on Nov 21, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put DWTX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

DWTX insider transactions

Dogwood Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Nov 21, 2025Sealbond Ltd & Conjoint Inc. & CK Life Sciences Intl (Holdings) IncDirectorConversion2,842,638—Form 4
Nov 21, 2025Sealbond Ltd & Conjoint Inc. & CK Life Sciences Intl (Holdings) IncDirectorConversion21,610,950—Form 4
Aug 21, 2023Pridgen WilliamDirectorBuy15,335$19.99KForm 4
Aug 17, 2023Duncan Gregory ScottCHIEF EXECUTIVE OFFICERBuy25,000$31.25KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related